Clinical oversight · for medical directors

The quality assurance layer for your organization.

Manual chart review samples 5–10% of visits, weeks late. RubikMD reviews 100% against named sources and returns a prioritized queue so leadership spends time where it matters. Read-only. You decide.

One export Friday → weekend review → Monday morning queue.

Open Monday review queue
100% Of the export reviewed — not a random sample
— Flags in this synthetic GLP-1 demo queue
0 Workflow change for treating clinicians

Every flag names its rulebook

FDA label — hard lines (contraindications, boxed warnings, dosing floors).

Society guidelines — how good medicine is practiced (legally weighted).

Clinic protocols — your own SOPs, so oversight matches how you actually run.

Kevin / KPMG walkthrough (~10 min)

  1. Coverage — see 100% of the batch reviewed vs typical sampling.
  2. Queue — open a high-priority flag; note which rulebook fired.
  3. Decide — confirm or dismiss; the oversight log is the receipt.

Demo only. Synthetic charts from the RubikMD cohort. Not PHI. Not a medical device. Not an insurer. Surfaces evidence for human disposition — including a stub for future liability-context agents (warning letters), never a legal verdict.